Retinal Macrophages Synthesize C3 and Activate Complement in AMD and in Models of Focal Retinal Degeneration
Author(s) -
Riccardo Natoli,
Nilisha Fernando,
Haihan Jiao,
Tanja Racic,
Michele C. Madigan,
Nigel L. Barnett,
Joshua A. ChuTan,
Krisztina Valter,
Jan Provis,
Matt Rutar
Publication year - 2017
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.17-21672
Subject(s) - macular degeneration , microglia , retina , retinal , complement system , retinal degeneration , lesion , biology , alternative complement pathway , pathology , factor h , microbiology and biotechnology , immunology , medicine , neuroscience , inflammation , immune system , ophthalmology , biochemistry
Complement system dysregulation is strongly linked to the progression of age-related macular degeneration (AMD). Deposition of complement including C3 within the lesions in atrophic AMD is thought to contribute to lesion growth, although the contribution of local cellular sources remains unclear. We investigated the role of retinal microglia and macrophages in complement activation within atrophic lesions, in AMD and in models of focal retinal degeneration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom